Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza

Publication

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

expert opinion -

This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.

Publication

Expert Opinion on neuraminidase inhibitors for prevention and treatment of influenza (Feb 2016)

expert opinion, public consultation -

A consultation with European and international public health experts was convened to review data presented in newly conducted systematic reviews and meta-analyses regarding influenza antivirals, in order to develop an ECDC Expert Opinion.

Related content on antiviral treatment of influenza

Publication

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

expert opinion -

News

New and updated evaluations of neuraminidase inhibitors for preventing and treating influenza published

ECDC comment -

News

How effective were neuraminidase inhibitors during the 2009 pandemic?

ECDC comment -

News

Effectiveness of the therapeutic and prophylactic use of antivirals during seasonal influenza – experience in Hong Kong

ECDC comment -

News

Differing effectiveness of the therapeutic and prophylactic use of antivirals and other measures for public health purposes during the 2009 influenza A(H1N1) pandemic

ECDC comment -